LLY

1,045.57

+3.75%↑

JNJ

230.89

+0.15%↑

ABBV

214.62

+0.91%↑

UNH

383.23

+0.51%↑

AZN

190.15

+1.08%↑

LLY

1,045.57

+3.75%↑

JNJ

230.89

+0.15%↑

ABBV

214.62

+0.91%↑

UNH

383.23

+0.51%↑

AZN

190.15

+1.08%↑

LLY

1,045.57

+3.75%↑

JNJ

230.89

+0.15%↑

ABBV

214.62

+0.91%↑

UNH

383.23

+0.51%↑

AZN

190.15

+1.08%↑

LLY

1,045.57

+3.75%↑

JNJ

230.89

+0.15%↑

ABBV

214.62

+0.91%↑

UNH

383.23

+0.51%↑

AZN

190.15

+1.08%↑

LLY

1,045.57

+3.75%↑

JNJ

230.89

+0.15%↑

ABBV

214.62

+0.91%↑

UNH

383.23

+0.51%↑

AZN

190.15

+1.08%↑

Search

Atossa Therapeutics Inc

Open

4.86 1.25

Overview

Share price change

24h

Current

Min

4.72

Max

4.98

Key metrics

By Trading Economics

Income

1.3M

-9.6M

EPS

-1.11

Employees

16

EBITDA

1.6M

-9.9M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+375.21% upside

Market Stats

By TradingEconomics

Market Cap

-9.3M

41M

Previous open

3.61

Previous close

4.86

Technical Score

By Trading Central

Confidence

Bullish Evidence

Atossa Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 Jan 2026, 23:29 UTC

Hot Stocks

Stocks to Watch: Atossa Therapeutics, Union Pacific

Peer Comparison

Price change

Atossa Therapeutics Inc Forecast

Price Target

By TipRanks

375.21% upside

12 Months Forecast

Average 23 USD  375.21%

High 25 USD

Low 20 USD

Based on 3 Wall Street analysts offering 12 month price targets forAtossa Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.7955 / 0.898Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat